Clinical Trial Update: A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fremanezumab for preventing migraine in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Fremanezumab (fremanezumab)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED